Avanir Pharmaceuticals (Nasdaq: AVNR) announced preliminary financial information (unaudited) for the year ended September 30, 2013, in anticipation of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE